Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Tele-Rehabilitation.
- Who it may be relevant to
- Registry conditions: COPD (Chronic Obstructive Pulmonary Disease), Rehabilitation, Bronchiectasis Adult, Pulmonary Arterial Hypertension (PAH). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Israel
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Tele-Pulmonary Rehabilitation to Improve Adherence and Management of Patients With Chronic Lung Diseases
Overview
Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups. This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups: 1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center. 2. The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.
Detailed description
Data collection:
Participants will be followed for 12 months after enrollment. Baseline data will include demographic characteristics, medical history and pulmonary function tests. Follow-up phone calls will be conducted at 1.5, 3, and 6 months to assess initiation of pulmonary rehabilitation, adherence, safety events, symptoms and healthcare utilization. An additional follow-up assessment will be conducted at 12 months after enrollment. Patient-reported outcomes will include respiratory symptom burden assessed using the Chronic Airways Assessment Test (CAAT), anxiety and depression assessed using the Hospital Anxiety and Depression Scale (HADS), knowledge assessed using the Lung Information Needs Questionnaire (LINQ), and patient satisfaction assessed using the Global Evaluation of Treatment Effectiveness (GETE). Adherence to tele-pulmonary rehabilitation will also be monitored using participation logs from the rehabilitation sessions.
Sample Size Calculation:
Based on prior studies, adherence to pulmonary rehabilitation is expected to be approximately 33% in the control group. The researchers hypothesize that tele-pulmonary rehabilitation will increase adherence to 66%. To detect this difference with a power of 80% and a significance level of 0.01, 35 participants are required in each group. Assuming a 20-25% loss of follow up, the total planned sample size is 90 participants (45 patients per group).
Randomization:
A total of 90 participants meeting the study inclusion criteria will be randomized in a 1:1 ratio to either the intervention or control group. Randomization will be stratified by the participating centers. Within each stratum, treatment assignments will be determined using a computer-generated random allocation sequence utilizing variable block sizes of two or four. To prevent selection bias and maintain strict allocation concealment, the randomization schedule will be generated and housed within a secure, centralized electronic system managed exclusively by an independent study coordinator. The clinical research team, including investigators responsible for patient enrollment and clinical care, will remain entirely removed from sequence generation and block determination. Allocation will be revealed sequentially on a patient-by-patient basis only after a participant's eligibility is confirmed and the index visit disposition is finalized.
Interventions
- Other Tele-Rehabilitation
Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided p
Primary outcome measures
- Adherence to pulmonary rehabilitation Between the Study Groups [Time frame: Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.]
Secondary outcome measures (12)
- Safety of Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation [Time frame: Assessed from enrollment to 6 months following study initiation.]
- Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate [Time frame: Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.]
- Global Evaluation of Treatment Effectiveness (GETE) score [Time frame: Will be asked by the clinical research coordinator via phone call after 6 months following study initiation.]
- Respiratory Symptoms Burden Assessed by CAAT [Time frame: Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.]
- Health Care Utilization [Time frame: Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.]
- Anxiety and Depression Assessed by HADS [Time frame: Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.]
- Change in Patient Knowledge and Information Needs [Time frame: Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.]
- Respiratory Symptoms Burden Assessed by mMRC Dyspnea Scale [Time frame: Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.]
- Time to Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation [Time frame: Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.]
- Adherence Rate Between The Study Groups [Time frame: Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.]
- Adherence to pulmonary rehabilitation Between the Study Groups - long term [Time frame: Assessed by a clinical research coordinator from enrollment to 12 months following study initiation.]
- Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate - long term [Time frame: Assessed by a clinical research coordinator from enrollment to 12 months following study initiation.]
Eligibility criteria
Inclusion criteria
- Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions:
- COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year.
- Interstitial lung disease with an FVC below 80% or a DLCO below 60%.
- Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%.
- Pulmonary arterial hypertension.
- Willingness to initiate a PR or Tele-PR (TPR) programs.
- Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
- Agree to participate, with signed informed consent.
Exclusion criteria
- Uncontrolled comorbidity (e.g uncontrolled congestive heart failure)
- Inability to operate the mobile application.
- Without a mobile device or computer.
- A hospitalization in the 2-months prior to randomization.
- Completed PR program in the last 12 months.
- Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance
- Pregnancy
- Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Israel · 2 centers
- Barzilai Medical Center — Ashkelon
- Tel Aviv Sourasky Medical Center — Tel Aviv
Identifiers
NCT: NCT07666841 · 0295-25-TLV